Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract

Blood (2023) 141 (12): 1389–1401.

https://doi.org/10.1182/blood.2021015111

Published: 2023

Includes: Supplemental data

Journal Articles

Interplay between Chromosomal Alterations and Gene Mutations Shapes the Evolutionary Trajectory of Clonal Hematopoiesis

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141882

Published: 2020

Journal Articles

Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Blood (2020) 136 (Supplement 1): 18–20.

https://doi.org/10.1182/blood-2020-137552

Published: 2020

Journal Articles

A Pilot Study Evaluating Lenalidomide and CC-486 in Combination with Radiotherapy for Patients with Plasmacytoma (LENAZART study)

Blood (2020) 136 (Supplement 1): 8–10.

https://doi.org/10.1182/blood-2020-141131

Published: 2020

Journal Articles

Secondary Graft-Versus-Host Disease (GVHD) Prophylaxis with Oral Proteasome Inhibitor Ixazomib Is Associated with Low Incidence of Recurrent, Late Acute and Chronic GVHD and Facilitated Calcineurin Inhibitor Taper within the First Year Post Allogeneic Stem Cell Transplantation

Natasia Rodriguez, BSN, Jasme Lee, Lisa Flynn, Fiona Murray, Sean Devlin, PhD, Cristina Soto Izquierdo, Christina Cho, MD, Parastoo B. Dahi, MD, Sergio A. Giralt, MD, Craig S. Sauter, MD, Miguel-Angel Perales, MD, Doris M Ponce, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-139666

Published: 2020

Journal Articles

Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients

Kelly L. Bolton, MD PhD, Michael Foote, MD, Justin Jee, Anton Safonov, MD, Ryan Ptashkin, MS, Sean Devlin, PhD, Erika Gedvilaite, Teng Gao, Elli Papaemmanuil, PhD, Melissa S. Pessin, MD PhD, Mini Kamboj, Joseph Vijai, PhD, Kenneth Offit, MD, Phillip Awadalla, PhD, Pradeep Nataranjan, Michael F. Berger, PhD, Larry Norton, MD, Ross L. Levine, MD, Ahmet Zehir, PhD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-143041

Published: 2020

Journal Articles

Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Patients with Multiple Myeloma Treated with Continuous Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 Study

Benjamin Diamond, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Eric L Smith, MDPhD, Urvi A Shah, MD, Sham Mailankody, MBBS, Malin Hultcrantz, MD PhD, Hani Hassoun, MD, Sydney X. Lu, MD PhD, Carlyn Tan, MD, Donna Massey, MSN, RN, Meghan Salcedo, BSN, RN, Victoria Diab, RN, Kelly Werner, RN, Jenna Rispoli, RN, Allison Sams, NP, Dennis Verducci, NP, Katie Jones, NP, Julia Schlossman, BA, Aisara Chansakul, BS, Angela Harrison, MS, Amanda Kathryn Ciardiello, Elizabet Tavitian, BS, Tala Shekarkhand, BS, Casey Piacentini, BS, Even H Rustad, MD PhD, Venkata D Yellapantula, Francesco Maura, MD, Tim J Peterson, PharmD, Andriy Derkach, PhD, Sean Devlin, PhD, Heather J Landau, MD, Michael Scordo, MD, David J. Chung, MD PhD, Gunjan L. Shah, MDMS, Oscar B Lahoud, MD, Katie Thoren, Kazunori Murata, Lakshmi Ramanathan, PhD, Maria E. Arcila, MD, Caleb Ho, MD, Mikhail Roshal, MD PhD, Ahmet Dogan, MD PhD, Sergio A. Giralt, MD, Ola Landgren, MD PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-140152

Published: 2020

Journal Articles

Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas

Brandon S. Imber, MD MA, Miguel-Angel Perales, MD, Jessica Flynn, BS, Josel D Ruiz, MPH, Sean Devlin, PhD, Ana Alarcon Tomas, MD, Carla Hajj, MD, Connie Lee Batlevi, MDPhD, Parastoo B. Dahi, MD, Richard J Lin, MDPhD, Jae H. Park, MD, Michael Scordo, MD, Gunjan L. Shah, MDMS, Sergio A. Giralt, MD, Craig S. Sauter, MD, M. Lia Palomba, MD, Joachim Yahalom, MD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-140991

Published: 2020

Journal Articles

Rabbit Anti-Thymocyte Globulin Exposure (rATG) in CD34+ Selected Hematopoietic Cell Transplantation and Its Impact on Immune Reconstitution and Outcomes in Children and Adults

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136341

Published: 2020

Journal Articles

Association of Patient Activity Bioprofiles with Hrqol and Clinical Responses: A Prospective Novel Trial Using Mobile Wearables in Newly Diagnosed Multiple Myeloma Patients

Blood (2020) 136 (Supplement 1): 26–28.

https://doi.org/10.1182/blood-2020-142082

Published: 2020

Journal Articles

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

Simon Mantha, MDMPH, Andrew Dunbar, MD, Kelly L. Bolton, MD PhD, Sean Devlin, PhD, Dmitriy Gorenshteyn, PhD, Mark Donoghue, PhD, Maria E. Arcila, MD, Gerald A. Soff, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-138579

Published: 2020

Journal Articles

RAS Pathway Mutations Are Associated with Proliferative Features and Frequently Co-Occur with TET2 mutationsin Philadelphia Negative MPN Subtypes

Bartlomiej M Getta, MBBS, Emily C Zabor, Sean Devlin, PhD, Kristina Marie Knapp, Minal Patel, BA, Abhinita Mohanty, Marcel van den Brink, MD PhD, Maria Arcila, MD, Ross L. Levine, MD, Rapaport Franck, Raajit K. Rampal, MD, PhD

Blood (2016) 128 (22): 4269.

https://doi.org/10.1182/blood.V128.22.4269.4269

Published: 2016

Journal Articles

A Pediatric-Inspired Regimen Containing Multiple Doses of Intravenous Pegylated Asparaginase Appears Safe and Effective in Newly Diagnosed Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Adults up to Age 60: Results of a Multi-Center Phase II Clinical Trial

Jae H. Park, MD, Ellen K. Ritchie, MD, Arati V. Rao, Sean Devlin, PhD, Meier Hsu, MS, Talal T Khawaja, B.S., Bridget A O'Donnell, B.S., Maria I Cazacu, B.S., Diane M Stopka, MS, Martin S. Tallman, MD, Dan Douer, MD

Blood (2016) 128 (22): 1629.

https://doi.org/10.1182/blood.V128.22.1629.1629

Published: 2016

Journal Articles

Comparison of Standard Assays (Serum Immunofixation and Protein Electrophoresis) with Hevylite Assay in Patients with Multiple Myeloma

Hani Hassoun, MD, Rosalynn Ruiz, BS, Murata Kazunori, PhD, Kathleen Azzi, Sean Devlin, PhD, Brittany Cooper, BS, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alexander M. Lesokhin, MD, David J Chung, MD PhD, Sham Mailankody, MD, Neha S Korde, MD, Sergio A. Giralt, MD, Ola Landgren, MD PhD

Blood (2016) 128 (22): 5626.

https://doi.org/10.1182/blood.V128.22.5626.5626

Published: 2016

Journal Articles

Comparable Survival and Incidence of Toxicity for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Gunjan L. Shah, MDMS, Michael Scordo, MD, Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Molly A. Maloy, MS, Jimmy Nieves, RN, Sean Devlin, PhD, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Brian C. Shaffer, MD, Miguel-Angel Perales, MD, Boglarka Gyurkocza, MD, Hugo R. Castro-Malaspina, MD, Sergio A. Giralt, MD, Roni Tamari, MD

Blood (2016) 128 (22): 1236.

https://doi.org/10.1182/blood.V128.22.1236.1236

Published: 2016

Journal Articles

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

Kristen Beyer, PharmD, Anthony Proli, PharmD, Junting Zheng, Sean Devlin, PhD, Valkal Bhatt, PharmD, Andrew Lin, PharmD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Miguel Perales, MD, Sergio Giralt, MD, Hugo Castro-Malaspina, MD, Roni Tamari, MD

Blood (2016) 128 (22): 3392.

https://doi.org/10.1182/blood.V128.22.3392.3392

Published: 2016

Journal Articles

TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Bartlomiej M Getta, MBBS, Arnab Ghosh, MD PhD, Catherine C. Coombs, MD, Sean Devlin, PhD, Maria Arcila, MD, Abhinita Mohanty, Ross L. Levine, MD, Martin S. Tallman, MD, Ann A. Jakubowski, MD PhD, Sergio A. Giralt, MD, Alan M Hanash, MD PhD

Blood (2016) 128 (22): 3481.

https://doi.org/10.1182/blood.V128.22.3481.3481

Published: 2016

Journal Articles

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Catherine C. Coombs, MD, Ahmet Zehir, PhD, Sean Devlin, PhD, Ashwin Kishtagari, MD, David M. Hyman, David Solit, MD, Mark Robson, MD, Jose Baselga, MD PhD, Maria Arcila, MD, Martin S. Tallman, MD, Ross L. Levine, MD, Michael Berger, PhD

Blood (2016) 128 (22): 37.

https://doi.org/10.1182/blood.V128.22.37.37

Published: 2016

Journal Articles

Impact of Treatment Center Characteristics on Early Death Rates in Patients with Newly Diagnosed Acute Promyelocytic Leukemia: Analysis of Data from the SEER Program

Jae H. Park, MD, Sean Devlin, PhD, Charles Lynch, Ann Schwartz, Theresa Keegan, PhD MS, Lou Gonsalves, Kim Hermit, MStat, Michael Green, Dan Douer, MD, Martin S. Tallman, MD

Blood (2016) 128 (22): 4008.

https://doi.org/10.1182/blood.V128.22.4008.4008

Published: 2016

Journal Articles

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Carmen Lau, PharmD, Valkal Bhatt, PharmD, Parastoo B. Dahi, MD, Sean Devlin, PhD, Yeon Yoo, BS, Nelly G. Adel, PharmD, BCOP, BCPS, Chris Mazis, Miguel Perales, MD, Sergio A. Giralt, MD, Guenther Koehne, MD PhD, Doris M Ponce, MD, Genovefa A Papanicolaou, MD, Juliet N. Barker, MBBS (Hons)

Blood (2016) 128 (22): 2219.

https://doi.org/10.1182/blood.V128.22.2219.2219

Published: 2016

NARROW

A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract

Interplay between Chromosomal Alterations and Gene Mutations Shapes the Evolutionary Trajectory of Clonal Hematopoiesis

Molecular Predictors and Effectiveness of Measurable Residual Disease (MRD) Eradication with Chemotherapy and Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

A Pilot Study Evaluating Lenalidomide and CC-486 in Combination with Radiotherapy for Patients with Plasmacytoma (LENAZART study)

Secondary Graft-Versus-Host Disease (GVHD) Prophylaxis with Oral Proteasome Inhibitor Ixazomib Is Associated with Low Incidence of Recurrent, Late Acute and Chronic GVHD and Facilitated Calcineurin Inhibitor Taper within the First Year Post Allogeneic Stem Cell Transplantation

Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients

Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Patients with Multiple Myeloma Treated with Continuous Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 Study

Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas

Rabbit Anti-Thymocyte Globulin Exposure (rATG) in CD34+ Selected Hematopoietic Cell Transplantation and Its Impact on Immune Reconstitution and Outcomes in Children and Adults

Association of Patient Activity Bioprofiles with Hrqol and Clinical Responses: A Prospective Novel Trial Using Mobile Wearables in Newly Diagnosed Multiple Myeloma Patients

Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism

RAS Pathway Mutations Are Associated with Proliferative Features and Frequently Co-Occur with TET2 mutationsin Philadelphia Negative MPN Subtypes

A Pediatric-Inspired Regimen Containing Multiple Doses of Intravenous Pegylated Asparaginase Appears Safe and Effective in Newly Diagnosed Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Adults up to Age 60: Results of a Multi-Center Phase II Clinical Trial

Comparison of Standard Assays (Serum Immunofixation and Protein Electrophoresis) with Hevylite Assay in Patients with Multiple Myeloma

Comparable Survival and Incidence of Toxicity for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Impact of Treatment Center Characteristics on Early Death Rates in Patients with Newly Diagnosed Acute Promyelocytic Leukemia: Analysis of Data from the SEER Program

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only